This book summarizes the present knowledge of oxidative stress in anti-cancer drug-induced cardiotoxicity and covers cell molecular mechanisms, prevention and treatment strategies, drug research, and population experiments. Racial and gender disparities in anticancer therapy-related cardiotoxicity are also covered. Book chapters provide current and timely review of hypothesis-driven research, case studies, and review articles. As such, this book serves as a source of knowledge and guidance for research, clinical prevention, and treatment of cardiotoxic anticancer drugs.

Furthermore, this book is essential for students, cardiologists, cardio-oncologists, and heart failure researchers.